| Celltech Regains Drug Rights from Pfizer |
Abstract
pdf
|
|
Business Review Editor |
|
| CAT Poised to Take Legal Action Against Abbott |
Abstract
pdf
|
|
Business Review Editor |
|
| Roche Reinvigorates Anti-Infective Franchise with Sankyo’s Antibiotic |
Abstract
pdf
|
|
Business Review Editor |
|
| Norwood Abbey Licenses Technology to TAP Pharmaceutical Products |
Abstract
pdf
|
|
Business Review Editor |
|
| CIMA Labs Licenses Fast-Dissolving Fentanyl to Taiho |
Abstract
pdf
|
|
Business Review Editor |
|
| Lilly Acquires AME to Optimize its Pipeline Proteins |
Abstract
pdf
|
|
Business Review Editor |
|
| Fujisawa Pharmaceutical Co. Ltd |
Abstract
pdf
|
|
Business Review Editor |
|
| Yamanouchi to Market Aventis’ Peptic Ulcer Drug Amidst Merger Talks |
Abstract
pdf
|
|
Business Review Editor |
|
